Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Amarantus BioScience Holdings, Inc. (AMBS) Starts Presentation at the Aegis Healthcare Conference

Amarantus BioScience Holdings, Inc. is a development-stage biotechnology company focusing on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases. The company is developing the Mesencephalic-Astrocyte-derived Neurotrophic Factor, a therapeutic protein for treating Parkinson’s diseases; LymPro, a blood test to diagnose Alzheimer’s disease; NuroPro to diagnose neurodegenerative diseases; and BC-SeraPro to diagnose breast cancer. For more information, visit the company’s website at

This entry was posted in Aegis Conference. Bookmark the permalink.

Comments are closed.